{
    "Allele Frequency": "0.22", 
    "Build 37 Chromosome": "chr16", 
    "Build 37 Position": "16251599", 
    "Build 37 Variant Allele": "T", 
    "Build37 coordinates:": [], 
    "Clinical Importance": "Low", 
    "Condition Tags": [
        "Metabolism"
    ], 
    "Evidence": "Uncertain", 
    "Gene Symbol": "ABCC6", 
    "Impact": "Pharmacogenetic", 
    "Inheritance": "Unknown", 
    "PMID Count": 4, 
    "PMID List": [
        "10811882", 
        "10913334", 
        "11776382", 
        "20038957"
    ], 
    "Scores": {
        "Case/Control": "3", 
        "Computational": "-1", 
        "Familial": "0", 
        "Functional": null, 
        "Penetrance": "1", 
        "Severity": "1", 
        "Treatability": "0"
    }, 
    "Summary": "This common polymorphism appears to not have a significant phenotypic impact. A few studies report weak but significant associations with plasma lipids (in Inuits) and thalidomide toxicity.", 
    "URL": "http://evidence.pgp-hms.org/ABCC6-R1268Q", 
    "Variant Name": "ABCC6-R1268Q", 
    "Variant Page": "http://evidence.pgp-hms.org/ABCC6-R1268Q", 
    "dbSNP IDs": [
        "rs2238472"
    ]
}